Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 59
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Epithelial cells provide immunocompetence to the early embryo for bacterial clearance

Epithelial cells provide immunocompetence to the early ...

 59

Mitochondrial origins of the pressure to sleep

Mitochondrial origins of the pressure to sleep

 108

Comparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration

Comparative transcriptomic profiling reveals a role for...

 57